rs886041019
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM2PP2PP3_StrongPP5_Very_Strong
The NM_006087.4(TUBB4A):c.1162A>G(p.Met388Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_006087.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:2
- -
The M388V variant in the TUBB4A gene has been reported previously in association with hypomyelinating leukodystrophy with atrophy of the basal ganglia and cerebellum (Hamilton et al., 2014; Miyatake et al., 2014). The M388V variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The M388V variant is a conservative amino acid substitution, which occurs at a position that is conserved across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Missense variants in the same residue (M388I, M388T) have also been reported in association with hypomyelinating leukodystrophy with atrophy of the basal ganglia and cerebellum (Hamilton et al., 2014; Posey et al., 2016), supporting the functional importance of this region of the protein. The M388V variant is a strong candidate for a pathogenic variant. -
Hypomyelinating leukodystrophy 6 Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at